These two new “weight loss” drugs have been getting a lot of attention: Semaglutide, a GLP1 (glucagon like peptide 1) receptor agonist, and Tirzepatide, a dual GLP1, and GIP...
Semaglutide vs Tirzepatide
read more
Keep In Touch
From our monthly Lunch and Learns with Dr. Yurth, to exciting developments in the longevity space, and insights from our team of specialists.